GlassScriptPhysician profile
Pei Lim Brian Lee
NPI 1982947131
$79,228.78
in general payments reported to CMS, 2019-2025
6 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,850 · 2023: $24K · 2024: $51K · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Travel and Lodging: $12K · Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,085.00 |
| Travel and Lodging | $11,938.83 |
| Food and Beverage | $354.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $45,869.36 | 2023-2024 | |
| Ipsen Bioscience INC. | $15,300.00 | 2024 | |
| Gilead Sciences, INC. | $13,875.00 | 2024 | |
| Corcept Therapeutics | $2,850.00 | 2020 | |
| Spectrum Pharmaceuticals INC. | $1,310.00 | 2025 | Rolvedon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.42 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pei Lim Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.